India, March 5 -- Shares of Bayer AG were gaining around 6 percent in the German trading after the pharmaceutical and life sciences major Wednesday said it expects improved performance from 2026 onwards, despite reporting a slip to loss in its fourth quarter. The company also projects weak core earnings and nearly flat sales for fiscal 2025.
Further, the company said it will propose an unchanged dividend of 0.11 euros per share at the Annual Stockholders' Meeting on April 25.
Calling 2025 a pivotal year for the company's turnaround, CEO Bill Anderson said, "It is the second year in Bayer's turnaround and will be the most difficult in terms of financial performance, with net sales roughly in line with and earnings and free cash flow behind...